Is Lixte Biotechnology Holdings, Inc. (LIXT) a Buy, Sell, or Hold?
NASDAQ : LIXT
Lixte Biotechnology Holdings, Inc. — Competitors
$7.21 USD
-$0.46 (-6.0%)
- Volume
- 615.06K
- Average Volume
- 238.6K
- Market Capitalization
- $89.11M
- P/E Ratio
- -6.38
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $8.38
- Year Low
- $2.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.78
LIXT vs. The Competition
| Properties | LIXT | ALLR | BCTX | CASI |
|---|---|---|---|---|
| Market Cap | $89.11M | $22.75M | $30.01M | $2.33M |
| Shares Outstanding | $12.36M | $15.91M | $8.7M | $15.49M |
| P/E Ratio | -6.38 | -1.99 | -0.28 | -0.07 |
| EPS | -0.67 | -0.7 | -4.23 | -2.18 |
| Day Low | 7 | 1.3701 | 3.41 | 0.15 |
| Day High | 7.95 | 1.55 | 3.58 | 0.1505 |
| Year Low | 2.02 | 0.769 | 2.6 | 0.135 |
| Year High | 8.38 | 2.35 | 14.68 | 3.09 |
| Average Price 50 | 5.8292 | 1.3347 | 3.3474 | 0.8562 |
| Average Price 200 | 4.31115 | 1.22993 | 5.4702 | 1.43505 |
| Volume | 615.06K | 127.5K | 60311 | 7897 |
| Average Volume | - | - | - | - |